IN2013MU02699A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02699A
IN2013MU02699A IN2699MU2013A IN2013MU02699A IN 2013MU02699 A IN2013MU02699 A IN 2013MU02699A IN 2699MU2013 A IN2699MU2013 A IN 2699MU2013A IN 2013MU02699 A IN2013MU02699 A IN 2013MU02699A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
isomeric
intermediates
advantage
Prior art date
Application number
Other languages
English (en)
Inventor
Virendra Kumar Agarwal
Ashish Rameshchandra Upadhyay
Nilesh Mansukhlal Thumar
Hardevsinh Kanaksinh Vala
Original Assignee
Amneal Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amneal Pharmaceuticals Llc filed Critical Amneal Pharmaceuticals Llc
Priority to US14/911,914 priority Critical patent/US9598403B2/en
Priority to PCT/US2014/051583 priority patent/WO2015026761A1/en
Priority to IN2699MU2013 priority patent/IN2013MU02699A/en
Publication of IN2013MU02699A publication Critical patent/IN2013MU02699A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
IN2699MU2013 2013-08-19 2014-08-19 IN2013MU02699A (lt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/911,914 US9598403B2 (en) 2013-08-19 2014-08-19 Process for the preparation of rivaroxaban
PCT/US2014/051583 WO2015026761A1 (en) 2013-08-19 2014-08-19 A process for the preparation of rivaroxaban
IN2699MU2013 IN2013MU02699A (lt) 2013-08-19 2014-08-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2699MU2013 IN2013MU02699A (lt) 2013-08-19 2014-08-19

Publications (1)

Publication Number Publication Date
IN2013MU02699A true IN2013MU02699A (lt) 2015-06-19

Family

ID=52484087

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2699MU2013 IN2013MU02699A (lt) 2013-08-19 2014-08-19

Country Status (3)

Country Link
US (1) US9598403B2 (lt)
IN (1) IN2013MU02699A (lt)
WO (1) WO2015026761A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110320306A (zh) * 2019-08-09 2019-10-11 南京科宁检测科技有限公司 衍生化hplc-dad测定利伐沙班基因毒杂质的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
WO2012051692A1 (en) * 2010-10-18 2012-04-26 Apotex Pharmachem Inc. Processes for the preparation of rivaroxaban and intermediates thereof
WO2013046211A1 (en) 2011-09-27 2013-04-04 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof

Also Published As

Publication number Publication date
US9598403B2 (en) 2017-03-21
US20160194309A1 (en) 2016-07-07
WO2015026761A1 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
NZ726859A (en) Synthesis of polycyclic-carbamoylpyridone compounds
PH12018501094A1 (en) Process for the preparation of an apoptosis-inducing agent
IN2012MU03723A (lt)
WO2013121436A3 (en) A process for preparation of rivaroxaban and intermediates thereof
NZ711192A (en) Process for making benzoxazepin compounds
IN2014MU00455A (lt)
IN2013MU03070A (lt)
IN2013MU01113A (lt)
IN2013MU01290A (lt)
IN2014DN07162A (lt)
IN2013MU02699A (lt)
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2015DN01814A (lt)
MX371011B (es) Intermediarios y métodos para sintetizar derivados de calicheamicina.
IN2013MU01219A (lt)
IN2013CH05865A (lt)
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
MX2015015346A (es) Procedimiento para la preparacion de intermediarios de acido boronico.
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
IN2013MU03768A (lt)
IN2013CH03963A (lt)
IN2013CH05863A (lt)
IN2014MU00069A (lt)
IN2013MU03250A (lt)
IN2013DE03592A (lt)